SCHEMBL6189063

SCHEMBL6189063

Cc1[nH]c(C(=O)O)c(O)c1N

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
CYP3A4 P08684 1/20 0.33
GPR35 Q9HC97 1/20 0.33
HPGD P15428 4/20 0.32
DAO P14920 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
KDM4E B2RXH2 4/20 0.31
GLA P06280 1/20 0.31
THRB P10828 1/20 0.31
MAPK1 P28482 1/20 0.31
GAA P10253 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13330260 0.77 GPR35 (0.40) ALDH1A1CYP1A2CYP3A4GPR35HPGD
SCHEMBL30829436 0.76 CYP1A2 (0.39) ALDH1A1CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL2457167 0.70 JAK2 (0.37) ALDH1A1GPR35HPGDKDM4ETHRB
SCHEMBL3156800 0.67 CYP1A2 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL16504003 0.64 CYP1A2 (0.70) ALDH1A1CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL13245759 0.64 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL510562 0.64 HCAR2 (0.42) DAOHCAR2
SCHEMBL5513393 0.64 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP3A4HPGDKDM4E
SCHEMBL19350085 0.63 ADORA1 (0.39) CYP1A2GPR35DAOHCAR2GAA
SCHEMBL31495905 0.63 GPR35 (0.45) ALDH1A1CYP1A2CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003072058-A2 DNA-BINDING POLYAMIDE DRUG CONJUGATES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTATED BY THE SECRETARY, DEPARMENT OF HEALTH AND HUMAN SERVICES (US) 2003-09-04 WO claimed
EP-1401817-A4 ISOQUINOLINE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY GENESOFT PHARMACEUTICALS INC (US) 2005-11-02 EP disclosed
EP-1470119-A4 BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY GENESOFT PHARMACEUTICALS INC (US) 2005-10-19 EP disclosed
EP-1470119-A1 BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY Genesoft, Inc. (US) 2004-10-27 EP disclosed
EP-1401817-A1 ISOQUINOLINE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY Genesoft Pharmaceuticals, Inc. (US) 2004-03-31 EP disclosed
WO-2002101073-A2 ARYL-BENZIMIDAZOLE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY GENESOFT PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
WO-2002100832-A1 ISOQUINOLINE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY GENESOFT PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
WO-2002100852-A1 BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY GENESOFT PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed